Location: Palo Alto, CA
CIK: 0001674712 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 14, 2022
Total Value: $906M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HRMY | Harmony Biosciences Holdings Inc | 3,400,261 | $151M | 16.6% | $36.16 | +34.9% | Common | 413197104 |
| — | Instil Bio Inc | 12,486,787 | $60.44M | 6.7% | $25.08 | — | Common | 45783C101 |
| VTYX | Ventyx Biosciences Inc | 1,355,861 | $47.33M | 5.2% | $18.57 | +19.2% | Common | 92332V107 |
| — | Verona Pharma PLC | 4,249,918 | $43.43M | 4.8% | $6.97 | — | ADS | 925050106 |
| ALXO | ALX Oncology Holdings Inc | 4,220,048 | $40.39M | 4.5% | $39.31 | -70.3% | Common | 00166B105 |
| TARS | Tarsus Pharmaceuticals Inc | 2,262,200 | $38.73M | 4.3% | $28.48 | -44.2% | Common | 87650L103 |
| SVA | Sinovac Biotech Ltd. | 5,900,000 | $38.17M | 4.2% | $6.47 | 0.0% | SHS | P8696W104 |
| GERN | Geron Corp | 15,238,095 | $35.66M | 3.9% | $1.11 | +100.8% | Common | 374163103 |
| TERN | Terns Pharmaceuticals Inc | 5,899,372 | $34.75M | 3.8% | $11.97 | -69.0% | Common | 880881107 |
| VRDN | Viridian Therapeutics Inc | 1,660,019 | $34.05M | 3.8% | $15.38 | +16.9% | Common | 92790C104 |
| COGT | Cogent Biosciences Inc | 1,883,941 | $28.11M | 3.1% | $7.93 | +72.8% | Common | 19240Q201 |
| RLMD | Relmada Therapeutics Inc | 713,238 | $26.4M | 2.9% | $22.29 | +24.3% | Common | 75955J402 |
| — | Allakos Inc | 4,120,134 | $25.21M | 2.8% | $6.12 | — | Common | 01671P100 |
| — | Amyris, Inc | 7,750,828 | $22.63M | 2.5% | $3.12 | — | Common | 03236M200 |
| KALV | KalVista Pharmaceuticals Inc. | 1,533,559 | $22.25M | 2.5% | $15.45 | -9.5% | Common | 483497103 |
| — | Chinook Therapeutics Inc | 872,151 | $17.15M | 1.9% | $15.86 | — | Common | 16961L106 |
| ASND | Ascendis Pharma A/S | 146,025 | $15.08M | 1.7% | $112.61 | — | SPONSORED ADR | 04351P101 |
| — | Avadel Pharmaceuticals PLC | 2,937,093 | $14.71M | 1.6% | $7.94 | — | ADR | 05337M104 |
| VERA | Vera Therapeutics Inc | 666,666 | $14.21M | 1.6% | $21.52 | -13.0% | Common | 92337R101 |
| ACRS | Aclaris Therapeutics, Inc. | 898,631 | $14.14M | 1.6% | $1.36 | +1057.4% | Common | 00461U105 |
| — | Impel NeuroPharma Inc | 2,884,789 | $14.05M | 1.6% | $8.85 | — | Common | 45258K109 |
| — | Cincor Pharma Inc | 349,237 | $11.46M | 1.3% | $32.82 | — | Common | 17240Y109 |
| — | Bellus Health Inc | 1,017,152 | $10.74M | 1.2% | $8.05 | — | Common | 07987C204 |
| LEGN | Legend Biotech Corp Sponsored | 244,375 | $9.971M | 1.1% | $42.56 | — | SPONSORED ADS | 52490G102 |
| PCVX | Vaxcyte Inc | 404,508 | $9.708M | 1.1% | $25.35 | 0.0% | Common | 92243G108 |
| ZLAB | Zai Lab Ltd ADR | 271,528 | $9.286M | 1.0% | $62.07 | — | ADR | 98887Q104 |
| — | Astria Therapeutics Inc | 1,000,000 | $9.04M | 1.0% | $9.04 | — | Common | 04635X102 |
| — | Merus NV | 442,000 | $8.853M | 1.0% | $21.00 | — | Common | N5749R100 |
| — | Iveric Bio Inc | 483,413 | $8.672M | 1.0% | $5.94 | — | Common | 46583P102 |
| IOBT | IO Biotech Inc | 3,015,545 | $8.172M | 0.9% | $9.66 | -61.6% | Common | 449778109 |
| — | Satsuma Pharmaceuticals Inc | 1,232,394 | $7.394M | 0.8% | $5.91 | — | Common | 80405P107 |
| DYN | Dyne Therapeutics Inc | 577,642 | $7.336M | 0.8% | $20.78 | -44.8% | Common | 26818M108 |
| WHWK | Aadi Bioscience Inc | 509,572 | $7.2M | 0.8% | $30.48 | -56.9% | Common | 00032Q104 |
| — | Genetron Holdings Ltd | 8,124,174 | $6.351M | 0.7% | $9.86 | — | ADS | 37186H100 |
| IOVA | Iovance Biotherapeutics Inc | 655,057 | $6.275M | 0.7% | $18.48 | -37.6% | Common | 462260100 |
| — | Bolt Therapeutics Inc | 3,871,291 | $5.73M | 0.6% | $32.91 | — | Common | 097702104 |
| CLDX | Celldex Therapeutics Inc | 198,983 | $5.593M | 0.6% | $11.14 | +175.3% | Common | 15117B202 |
| — | DBV Technologies SA | 2,708,875 | $4.795M | 0.5% | $1.77 | — | Sponsored ADR | 23306J101 |
| OLMA | Olema Pharmaceuticals Inc | 1,689,515 | $4.663M | 0.5% | $39.90 | -89.4% | Common | 68062P106 |
| CMPX | Compass Therapeutics Inc | 2,000,000 | $4.56M | 0.5% | $3.29 | -15.8% | Common | 20454B104 |
| ARWR | Arrowhead Pharmaceuticals Inc | 137,411 | $4.541M | 0.5% | $40.33 | +0.1% | Common | 04280A100 |
| — | Aligos Therapeutics Inc | 3,547,030 | $3.902M | 0.4% | $27.65 | — | Common | 01626L105 |
| — | Gracell Biotechnologies Inc | 961,359 | $3.096M | 0.3% | $15.40 | — | SPONSORED ADS | 38406L103 |
| SERA | Sera Prognostics Inc | 1,856,011 | $2.97M | 0.3% | $10.38 | -80.6% | Common | 81749D107 |
| CDXS | Codexis, Inc | 388,144 | $2.352M | 0.3% | $13.98 | -42.5% | Common | 192005106 |
| — | Minerva Surgical Inc | 2,215,667 | $1.762M | 0.2% | $5.14 | — | Common | 60343F106 |
| — | Aslan Pharmaceuticals Ltd | 2,840,909 | $1.701M | 0.2% | $3.35 | — | ADS | 04522R101 |
| RZLT | Rezolute Inc | 489,473 | $1.341M | 0.1% | $3.32 | -13.1% | Common | 76200L309 |
| — | Homology Medicines, Inc. | 370,068 | $596K | 0.1% | $15.54 | — | Common | 438083107 |
| — | Precision Biosciences Inc | 140,255 | $182K | 0.0% | $6.03 | — | Common | 74019P108 |
| — | Metacrine Inc | 146,426 | $71,000 | 0.0% | $10.21 | — | Common | 59101E103 |